HeartSciences Inc.
HSCS
$3.08
$0.269.22%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.86% | -0.16% | -13.44% | -54.29% | -19.13% |
| Total Depreciation and Amortization | -5.81% | -4.80% | 4.33% | 21.85% | 137.24% |
| Total Amortization of Deferred Charges | 299.85% | -- | -- | 431.40% | -20.39% |
| Total Other Non-Cash Items | 945.96% | 170.28% | 43.78% | -72.48% | -81.30% |
| Change in Net Operating Assets | -203.87% | -230.66% | 73.61% | 203.10% | -157.88% |
| Cash from Operations | -6.90% | 3.23% | -0.88% | 22.89% | -120.97% |
| Capital Expenditure | -306.25% | -- | 100.00% | 100.00% | 53.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 0.00% | 61.76% | 61.14% | -155.10% |
| Cash from Investing | -172.41% | 0.00% | 88.73% | 68.09% | -190.00% |
| Total Debt Issued | -- | -- | -- | -- | 453.65% |
| Total Debt Repaid | -497.99% | -184.26% | 3.78% | -41.27% | 30.02% |
| Issuance of Common Stock | 42.69% | -- | -62.03% | -97.26% | -56.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.66% | 561.28% | -73.48% | -98.03% | 269.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.35% | 215.41% | -18.10% | -120.86% | 39.50% |